for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Polyphor Temporarily Halts Enrollment In Phase III Studies Of Murepavadin

May 9 (Reuters) - Polyphor AG:

* POLYPHOR TEMPORARILY HALTS ENROLLMENT IN PHASE III STUDIES OF MUREPAVADIN FOR TREATMENT OF PATIENTS WITH NOSOCOMIAL PNEUMONIA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up